Lidocaine Effects on Neutrophil Extracellular Trapping and Angiogenesis Biomarkers in Postoperative Breast Cancer Patients with Different Anesthesia Methods: a Prospective, Randomized Trial

Overview

Journal BMC Anesthesiol

Publisher Biomed Central

Specialty Anesthesiology

Date 2024 Apr 27

PMID 38678209

Authors

Wenjuan Zhang

Jiao Liu

Xiaohui Li

Zhixia Bai

Yan Sun

Xuexin Chen

Affiliations

Soon will be listed here.

Abstract

Background: Anesthesia techniques and drug selection may influence tumor recurrence and metastasis. Neutrophil extracellular trapping (NETosis), an immunological process, has been linked to an increased susceptibility to metastasis in individuals with tumors. Furthermore, recurrence may be associated with vascular endothelial growth factor A (VEGF-A), a mediator of angiogenesis. This study investigates the impact of lidocaine (combined with sevoflurane or propofol anesthesia ) during breast cancer surgery inhibits the expression of biomarkers associated with metastasis and recurrence (specifically H3Cit, NE, MPO, MMP-9 and VEGF-A).

Methods: We randomly assigned 120 women undergoing primary or invasive breast tumor resection to receive one of four anesthetics: sevoflurane (S), sevoflurane plus i.v. lidocaine (SL), propofol (P), and propofol plus i.v. lidocaine (PL). Blood samples were collected before induction and 3 h after the operation. Biomarkers associated with NETosis (citrullinated histone H3 [H3Cit], myeloperoxidase [MPO], and neutrophil elastase [NE]) and angiogenesis were quantified using enzyme-linked immunosorbent assays.

Results: Patient and breast tumor characteristics, along with perioperative management, did not differ between study groups. In intra-group comparisons, S and P groups demonstrated a statistically significant increase in post-operative MPO (S group: 10.39[6.89-17.22] vs. 14.31[8.55-20.87] ng ml-1, P = 0.032; P group: 9.45[6.73-17.37] vs. 14.34[9.87-19.75] ng ml-1, P = 0.035)and NE(S group: 182.70[85.66-285.85] vs. 226.20[91.85-391.65] ng ml-1, P = 0.045; P group: 154.22[97.31-325.30] vs. 308.66[132.36-483.57] ng ml-1, P = 0.037) concentrations compared to pre-operative measurements, whereas SL and PL groups did not display a similar increase. H3Cit, MMP-9, and VEGF-A concentrations were not significantly influenced by the anesthesia techniques and drugs.

Conclusions: Regardless of the specific technique employed for general anesthesia, there was no increase in the postoperative serum concentrations of MPO and NE after perioperative lidocaine infusion compared to preoperative serum concentrations. This supports the hypothesis that intravenous lidocaine during cancer surgery aimed at achieving a cure may potentially decrease the likelihood of recurrence. Further interpretation and discussion of clinical implications are warranted, emphasizing the significance of these findings in the context of cancer surgery and recurrence prevention.

Clinical Trial Registration: ChiCTR2300068563.

Citing Articles

Harnessing myeloid cells in cancer.

Park S, Pylaeva E, Bhuria V, Gambardella A, Schiavoni G, Mougiakakos D Mol Cancer. 2025; 24(1):69.

PMID: 40050933 PMC: 11887392. DOI: 10.1186/s12943-025-02249-2.

References

Albrengues J, Shields M, Ng D, Park C, Ambrico A, Poindexter M . Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018; 361(6409). PMC: 6777850. DOI: 10.1126/science.aao4227. View

Huang H, Benzonana L, Zhao H, Watts H, Perry N, Bevan C . Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br J Cancer. 2014; 111(7):1338-49. PMC: 4183852. DOI: 10.1038/bjc.2014.426. View

Galos E, Tat T, Popa R, Efrimescu C, Finnerty D, Buggy D . Neutrophil extracellular trapping and angiogenesis biomarkers after intravenous or inhalation anaesthesia with or without intravenous lidocaine for breast cancer surgery: a prospective, randomised trial. Br J Anaesth. 2020; 125(5):712-721. DOI: 10.1016/j.bja.2020.05.003. View

Freeman J, Crowley P, Foley A, Gallagher H, Iwasaki M, Ma D . Effect of Perioperative Lidocaine and Cisplatin on Metastasis in a Murine Model of Breast Cancer Surgery. Anticancer Res. 2018; 38(10):5599-5606. DOI: 10.21873/anticanres.12894. View

Lu Y, Qin T, Li J, Wang L, Zhang Q, Jiang Z . MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer. Cancer Gene Ther. 2017; 24(9):386-392. PMC: 5668497. DOI: 10.1038/cgt.2017.30. View

Monti M, Iommelli F, De Rosa V, Carriero M, Miceli R, Camerlingo R . Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells. PLoS One. 2017; 12(2):e0171362. PMC: 5293257. DOI: 10.1371/journal.pone.0171362. View

Wigmore T, Mohammed K, Jhanji S . Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis. Anesthesiology. 2015; 124(1):69-79. DOI: 10.1097/ALN.0000000000000936. View

Snoderly H, Boone B, Bennewitz M . Neutrophil extracellular traps in breast cancer and beyond: current perspectives on NET stimuli, thrombosis and metastasis, and clinical utility for diagnosis and treatment. Breast Cancer Res. 2019; 21(1):145. PMC: 6921561. DOI: 10.1186/s13058-019-1237-6. View

Xing S, Zhang K, Qu J, Ren Y, Luan Q . Propofol induces apoptosis of non-small cell lung cancer cells via ERK1/2-dependent upregulation of PUMA. Eur Rev Med Pharmacol Sci. 2018; 22(13):4341-4349. DOI: 10.26355/eurrev_201807_15431. View

10.

Siddiqui R, Zerouga M, Wu M, Castillo A, Harvey K, Zaloga G . Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells. Breast Cancer Res. 2005; 7(5):R645-54. PMC: 1242121. DOI: 10.1186/bcr1036. View

11.

Schulz K, Altman D, Moher D . CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother. 2011; 1(2):100-7. PMC: 3043330. DOI: 10.4103/0976-500X.72352. View

12.

Wall T, Crowley P, Sherwin A, Foley A, Buggy D . Effects of Lidocaine and Src Inhibition on Metastasis in a Murine Model of Breast Cancer Surgery. Cancers (Basel). 2019; 11(10). PMC: 6826872. DOI: 10.3390/cancers11101414. View

13.

Badwe R, Parmar V, Nair N, Joshi S, Hawaldar R, Pawar S . Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer. J Clin Oncol. 2023; 41(18):3318-3328. DOI: 10.1200/JCO.22.01966. View

14.

Iwasaki M, Zhao H, Jaffer T, Unwith S, Benzonana L, Lian Q . Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget. 2016; 7(18):26042-56. PMC: 5041963. DOI: 10.18632/oncotarget.8304. View

15.

Pircher A, Hilbe W, Heidegger I, Drevs J, Tichelli A, Medinger M . Biomarkers in tumor angiogenesis and anti-angiogenic therapy. Int J Mol Sci. 2011; 12(10):7077-99. PMC: 3211028. DOI: 10.3390/ijms12107077. View

16.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

17.

Estebe J . Intravenous lidocaine. Best Pract Res Clin Anaesthesiol. 2018; 31(4):513-521. DOI: 10.1016/j.bpa.2017.05.005. View

18.

Petretto A, Bruschi M, Pratesi F, Croia C, Candiano G, Ghiggeri G . Neutrophil extracellular traps (NET) induced by different stimuli: A comparative proteomic analysis. PLoS One. 2019; 14(7):e0218946. PMC: 6613696. DOI: 10.1371/journal.pone.0218946. View

19.

Enlund M, Berglund A, Enlund A, Lundberg J, Warnberg F, Wang D . Impact of general anaesthesia on breast cancer survival: a 5-year follow up of a pragmatic, randomised, controlled trial, the CAN-study, comparing propofol and sevoflurane. EClinicalMedicine. 2023; 60:102037. PMC: 10276257. DOI: 10.1016/j.eclinm.2023.102037. View

20.

Lamouille S, Xu J, Derynck R . Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15(3):178-96. PMC: 4240281. DOI: 10.1038/nrm3758. View